Ella Balasa- Cystic Fibrosis Patient Advocate

<p>In this episode of the Clinical Research Coach, I sit down with Ella Balasa, a cystic fibrosis patient advocate whose lived experience is shaping how our industry understands trust, transparency, and meaningful patient engagement.</p><p><br></p><p>Diagnosed in infancy with cystic fibrosis, a progressive genetic lung disease, Ella has spent her life navigating hospital systems, breakthrough therapies, and clinical trials — not as an abstract participant, but as someone whose health and future depend on research progress. Along the way, she has become a powerful voice for improving how industry partners with patients.</p><p><br></p><p>In this conversation, Ella shares what sponsors, sites, and biotech leaders often overlook:</p><p>* Patient experience is never one-size-fits-all — even within the same diagnosis.</p><p>* Patients learn about trials through trusted networks, not just databases or digital ads.</p><p>* Transparency builds confidence and drives long-term participation in research.</p><p>* Dropout affects more than timelines — it influences trust and future enrollment decisions.</p><p>* Technology should support patients, but never replace human connection.</p><p><br></p><p>Ella’s perspective challenges us to think beyond enrollment metrics and toward something deeper: relational trust. Because sustainable progress in clinical research depends on listening to patients as individuals, partners, and experts in their own lives.</p><p><br></p><p>To learn more about Ella:</p><p>Https:/ellabalasa.com</p><p><br></p>